
Written based on 1 research study on PubMed, searched on 2026. nov. 11..
The claim
Posts online say that fenbendazole helps with triple-negative breast cancer.
Where research stands
We found 1 published paper on fenbendazole and triple-negative breast cancer. They were published between 2023 and 2023. None of them is a study in people. None was a study in animals, and 1 was only in cells in the lab.
- 0In people
- 0In animals
- 1Only in the lab
What the studies found
We have not summed up these studies in words yet. The most important papers are listed under Sources.
Verdict
Fenbendazole has been studied for triple-negative breast cancer only in cells in the lab.
Unproven means: it was only tested in animals or cells, or there is too little or mixed data from people. How we rate claims
What this means for you: Results in animals or in cells often do not hold in people. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.
Sources
- Redox-mediated Anticancer Activity of Anti-parasitic Drug Fenbendazole in Triple-negative Breast Cancer Cells.2023 · Anticancer Res · In the lab


